49 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 1
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
CACNA1ACalcium voltage-gated channel subunit alpha1 ADisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enhanced
CACNA1BCalcium voltage-gated channel subunit alpha1 BDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium voltage-gated channel subunit alpha1 CDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium voltage-gated channel subunit alpha1 DCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneMixed
CACNA1FCalcium voltage-gated channel subunit alpha1 FDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1GCalcium voltage-gated channel subunit alpha1 GDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium voltage-gated channel subunit alpha1 HDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Vesicles
Tissue enhanced
CACNA1ICalcium voltage-gated channel subunit alpha1 IFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium voltage-gated channel subunit alpha1 SDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA1Potassium voltage-gated channel subfamily A member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel subfamily A member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Not detected
KCNA2Potassium voltage-gated channel subfamily A member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium voltage-gated channel subfamily A member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel subfamily A member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA7Potassium voltage-gated channel subfamily A member 7FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium voltage-gated channel subfamily B member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody
Tissue enhanced
KCNC1Potassium voltage-gated channel subfamily C member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol
Tissue enriched
KCNC2Potassium voltage-gated channel subfamily C member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND1Potassium voltage-gated channel subfamily D member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH2Potassium voltage-gated channel subfamily H member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium voltage-gated channel subfamily J member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium voltage-gated channel subfamily J member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ8Potassium voltage-gated channel subfamily J member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK2Potassium two pore domain channel subfamily K member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium two pore domain channel subfamily K member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK9Potassium two pore domain channel subfamily K member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNMA1Potassium calcium-activated channel subfamily M alpha 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium calcium-activated channel subfamily N member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel subfamily Q member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel subfamily Q member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium voltage-gated channel subfamily Q member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN10ASodium voltage-gated channel alpha subunit 10Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Not detected
SCN11ASodium voltage-gated channel alpha subunit 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
SCN1ASodium voltage-gated channel alpha subunit 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Nuclear bodies
Plasma membrane
Group enriched
SCN2ASodium voltage-gated channel alpha subunit 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN3ASodium voltage-gated channel alpha subunit 3FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN4ASodium voltage-gated channel alpha subunit 4Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Microtubule organizing center
Group enriched
SCN5ASodium voltage-gated channel alpha subunit 5Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN9ASodium voltage-gated channel alpha subunit 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Focal adhesion sites
Tissue enhanced
TRPA1Transient receptor potential cation channel subfamily A member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM8Transient receptor potential cation channel subfamily M member 8FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
TRPV1Transient receptor potential cation channel subfamily V member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
Page of 1